Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) is associated with a naive B-cell phenotype in human tonsils

Tissue Antigens

Volumn 56, Issue 2, 2000, Pages 105-116

  Jackson, Denise E ^a,c   Gully, L M ^a   Henshall, T L ^a   Mardell, C E ^b   Macardle, P J ^b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c HANSON INSTITUTE   (Australia)

Author keywords

B cell differentiation; Germinal centre specific B cells; Human tonsils; Inhibitory receptor; Naive follicular mantle zone B cells; Platelet endothelial cell adhesion molecule 1

Indexed keywords

CD19 ANTIGEN; CD31 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL CLONING; CELL DIFFERENTIATION; CELL SELECTION; CELL SEPARATION; CELL SUBPOPULATION; FLUORESCENCE; GENE AMPLIFICATION; GENE LOCUS; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN GENE; IMMUNOHISTOCHEMISTRY; MULTIGENE FAMILY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SOMATIC MUTATION; T LYMPHOCYTE; TONSIL; TONSIL CELL;

ANTIGENS, CD; ANTIGENS, CD19; ANTIGENS, CD27; ANTIGENS, CD31; ANTIGENS, CD80; ANTIGENS, CD86; B-LYMPHOCYTES; CELL DIFFERENTIATION; FLOW CYTOMETRY; GENE EXPRESSION; GERMINAL CENTER; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE HOMOLOGY, NUCLEIC ACID; TONSIL;

EID: 0033868475     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2000.560201.x     Document Type: Article

References (39)

1. 1. Bancherequ J, Rousset F. Human B lymphocytes: phenotype, proliferation, and differentiation. Adv Immunol 1992: 52: 125-262.
2. 2. Gray D. Immunological memory. Annu Rev Immunol 1993: 11:49-77.
3. 3. Liu YJ, Grouard G, de Bouteiller O, Banchereau J. Follicular dendritic cells and germinal centres. Int Rev Cytol 1996: 166: 139-79.
4. 4. MacLennan IC, Liu Y-J, Johnson GD. Maturation and dispersal of B-cell clones during T-cell-dependent antibody responses. Immunol Rev 1992: 126: 143-61.
5. 5. Thorbecke GJ, Amin AR, Tsiagbe VK. Biology of germinal centers in lymphoid tissue. FASEB J 1994: 8: 832-40.
6. 6. MacLennan IC. Germinal centers. Annu Rev Immunol 1994: 12: 117-39.
7. 7. Han S, Zheng B, Takahashi Y, Kelsoe G. Distinctive characteristics of germinal center B cells. Semin Immunol 1997: 9: 255-60.
8. 8. Liu Y-J, Arpin C. Germinal center development. Immunol Rev 1997: 156: 111-26.
9. 9. Liu Y-J, Arpin C, de Bouteiller O et al. Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center development. Semin Immunol 1996: 8: 169-77.
10. 10. Liu Y-J, Banchereau J. The paths and molecular controls of peripheral B-cell development. Immunologist 1996: 4: 55-66.
11. 11. Pascual V, Liu Y-J, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B-cell subsets of human tonsil. J Exp Med 1994: 180: 329-39.
12. 12. Nicholson IC, Brisco MJ, Zola H. Memory B lymphocytes in human tonsil do not express surface IgD. J Immunol 1995: 154: 1105-13.
13. 13. Liu Y-J, Arpin C, de Bouteiller O et al. Within germinal centers, somatic mutation and isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity 1996: 4: 241-50.
14. 14. Liu Y-J, Barthelemy C, de Bouteiller O, Arpin C, Durand I, Banchereau J. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity 1995: 2: 239-48.
15. 15. Newman PJ. Switched at birth: a new family for PECAM-1. J Clin Invest 1999: 103: 5-9.
16. 16. Duncan GS, Andrew DP, Takimoto H et al. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol 1999: 162: 3022-30.
17. 17. Jackson DE, Ward CM, Wang R, Newman PJ. The protein-tyrosine phosphatase SHP-2 binds PECAM-1 and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1 and integrin-mediated cellular signaling. J Biol Chem 1997: 272: 6986-93.
18. 18. Sagawa K, Kimura T, Swieter M, Siraganian RP. The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule-1, PECAM-1 (CD31). J Biol Chem 1997: 272: 31086-91.
19. 19. Lu TT, Barreuther M, Davis S, Madri JA. Platelet endothelial cell adhesion molecule-1 is phosphorylatable by c-Src, binds Src-Src homology 2 domain, and exhibits immunoreceptor tyrosine-based activation motif-like properties. J Biol Chem 1997: 272: 14442-6.
20. 20. Hua CT, Gamble JR, Vadas MA, Jackson DE. Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). J Biol Chem 1998: 273: 28332-40.
21. 21. Newton-Nash DK, Newman PJ. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J Immunol 1999: 163: 682-8.
22. + hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes. Blood 1993: 82: 2649-63.
23. 23. Muller WA. CD31 workshop panel report. In: Kishimoto T, Kikutani H, von dem Berne A et al., eds. Leukocyte Typing VI. New York: Garland Press, 1997: 362-4.
24. 24. Amigorena S, Bonnerot C, Choquet D, Fridman WH, Teillaud JL. Fc gamma RII expression in resting and activated B lymphocytes. Eur J Immunol 1989: 19: 1379-85.
25. 25. Kubagawa H, Chen C-C, Ho LH et al. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. J Exp Med 1999: 189: 309-17.
26. 26. Perfetti V, Vignarelli MC, Bellotti V et al. Membrane CD22 defines circulating myeloma-related cells as mature or later B cells. Lab Invest 1997: 77: 333-44.
27. 27. Dorken B, Moldenhauer G, Pezzutto A et al. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J Immunol 1986: 136: 4470-9.
28. 28. van der Vuurst de Vries AR, Overs H, Logtenberg T, Meyaard L. Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is differentially expressed during human B-cell differentiation and inhibits B-cell receptor-mediated signaling. Eur J Immunol 1999: 29: 3160-7.
29. 29. Sun QH, DeLisser HM, Zukowski MM, Paddock C, Albelda SM, Newman PJ. Individual distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J Biol Chem 1996: 271: 11090-8.
30. 30. Zola H. Detection of cytokine receptors at the cell surface by flow cytometry. In: Robinson JP, Darzynkiewicz Z, Dean NP et al., eds. Current protocols in cytometry. New York: Wiley, 1995.
31. 31. Gumina RJ, Kirschbaum NE, Piotrowski K, Newman PJ. Characterization of the human platelet/endothelial cell adhesion molecule-1 promoter: identification of a GATA-2 binding element required for optimal transcriptional activity. Blood 1997: 89: 1260-9.
32. 32. Tomlinson IM, Walter G, Marks JD, Llewelyn MB, Winter G. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol 1992: 227: 776-98.
33. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998: 188: 1679-89.
34. 34. Govender D, Harilal P, Dada M, Chetty R. CD31 (JC70) expression in plasma cells: an immunohistochemical analysis of reactive and neoplastic plasma cells. J Clin Pathol 1997: 50: 490-3.
35. 35. Fernandez JE, Deaglio S, Donati D et al. Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues. J Biol Regul Homeost Agents 1998: 12:81-91.
36. 36. Oliver AM, Martin F, Gartland GL, Carter RH, Kearney JF. Marginal zone B cells exhibit unique activation proliferative and immunoglobulin secretory responses. Eur J Immunol 1997: 27: 2366-74.
37. 37. Gupta N, Scharenberg AM, Burshtyn DN et al. Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIb1 require distinct phosphatases. J Exp Med 1997: 186:473-8.
38. 38. Ono M, Okada H, Bolland S, Yanagi S, Kurosaki T, Ravetch JV. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 1997: 90: 293-301.
39. 39. Valiante NM, Phillips JH, Lanier LL, Parham P. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/ PLC-signaling complex in human natural killer (NK) cells. J Exp Med 1996: 184: 2243-50.